Immediate Impact

90 standout
Sub-graph 1 of 21

Citing Papers

New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
19 intermediate papers

Works of Wei-Shou Hwang being referenced

Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
2012
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
2008

Author Peers

Author Last Decade Papers Cites
Wei-Shou Hwang 116 49 47 257 234 11 405
Izhar Levy 59 99 30 273 198 10 398
Jonathan Israel 84 77 31 191 207 12 456
T. Suedhoff 226 67 96 138 194 14 458
Antonin Kayser 170 25 105 154 234 7 443
K Hino 42 76 28 251 236 13 366
Loredana Sansonno 27 52 44 303 146 12 420
Johanna K. Delladetsima 76 69 30 248 231 17 355
Hiroyuki Hagiyama 56 24 48 102 145 20 372
Nobuyoshi Tajiri 112 77 48 233 119 11 353
Shao‐Liang Zhu 46 90 54 267 144 18 342

All Works

Loading papers...

Rankless by CCL
2026